Edition:
India

Aptevo Therapeutics Inc (APVO.OQ)

APVO.OQ on NASDAQ Stock Exchange Global Select Market

5.04USD
24 Sep 2018
Change (% chg)

$0.09 (+1.82%)
Prev Close
$4.95
Open
$4.91
Day's High
$5.09
Day's Low
$4.91
Volume
18,945
Avg. Vol
27,809
52-wk High
$6.30
52-wk Low
$1.92

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 6.83 -0.582
Mar '18 4.07 -0.631
FY 2017 Dec '17 2.82 -0.443
Sep '17 6.17 0.138
Jun '17 3.53 -0.666
Mar '17 2.14 -0.564
FY 2016 Dec '16 2.78 -0.798
Sep '16 2.82 -3.628
Jun '16 10.19 -0.635
Mar '16 8.07 -0.638
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 2 6.87 6.89 6.85 --
Quarter Ending Dec-18 2 6.98 7.00 6.96 --
Year Ending Dec-18 2 24.75 24.75 24.75 --
Year Ending Dec-19 2 29.10 30.00 28.20 --
Earnings (per share)
Quarter Ending Sep-18 2 -0.59 -0.58 -0.60 --
Quarter Ending Dec-18 2 -0.61 -0.56 -0.65 --
Year Ending Dec-18 2 -2.41 -2.36 -2.47 --
Year Ending Dec-19 2 -2.35 -2.02 -2.68 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % 8.43 498.44 10.52
EPS (TTM) % -89.29 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aptevo Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 45.95 40.91 99 --
13 Week 41.36 34.48 99 --
26 Week 44.39 33.41 99 --
52 Week -2.17 -17.08 99 --
YTD 10.66 -2.82 99 --
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 33.32%
# of Holders: 73
Total Shares Held: 7,554,457
3 Mo. Net Change: -216,069
# New Positions: 12
# Closed Positions: 10
# Increased Positions: 32
# Reduced Positions: 25
# Net Buyers: 7
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.